Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boniscontro & Gazzone was a prominent Italian pharmaceutical manufacturer founded in the early 20th century and based in Turin. The company earned a significant reputation for developing popular over-the-counter (OTC) medicines and galenical preparations, particularly in the respiratory and gastrointestinal categories. Its portfolio featured iconic Italian brands such as Sciroppo Boniscontro and early versions of the antacid Citrosodina. Following its acquisition by Laboratorio Farmaceutico SIT, the company's operations and brands were integrated into the parent organization's structure. Today, it is recognized as a foundational entity in the history of the Italian medicinal industry, with its legacy products still recognized in the Mediterranean market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boniscontro and Gazzone.